Hankook Cosmetics Co., Ltd

As of June 30, 2026, Hankook Cosmetics Co., Ltd carries a market capitalization of 101.70B, placing it among publicly traded companies globally. Its enterprise value stands at 86.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Hankook Cosmetics Co., Ltd has 16.07M shares outstanding.

As of June 30, 2026, Hankook Cosmetics Co., Ltd trades at a trailing price-to-earnings ratio of 115.60. The price-to-sales ratio is 1.24, and the price-to-book ratio stands at 2.92.

As of June 30, 2026, Hankook Cosmetics Co., Ltd trades at an EV/EBITDA multiple of 36.78 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.05 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 146.20 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Hankook Cosmetics Co., Ltd trades at an EV/FCF ratio of 13.97, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 86.31B versus a market cap of 101.70B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hankook Cosmetics Co., Ltd maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.25, indicating elevated leverage, while an interest coverage ratio of 8.96 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Hankook Cosmetics Co., Ltd posted a return on equity (ROE) of 2.61, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.40 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.50, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.91, useful for judging operating efficiency across full business cycles. The company generates approximately 1.73B in revenue per employee across its workforce of 47.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.83 indicates how many times Hankook Cosmetics Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hankook Cosmetics Co., Ltd recorded 82.55M in income tax expense. That works out to an effective tax rate of 8.78, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 940.66M, leaving 880.63M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Hankook Cosmetics Co., Ltd's stock has declined approximately 44.39% over the past 52 weeks. The 50-day moving average sits at 6,350.80, while the 200-day moving average is 7,763.85.

Over the twelve months ended June 30, 2026, Hankook Cosmetics Co., Ltd generated 81.87B in revenue and converted that into 880.63M in net income, yielding earnings per share of 53.36. EBITDA reached 2.35B, while operating income came in at 608.24M.

As of June 30, 2026, Hankook Cosmetics Co., Ltd holds 20.44B in cash and equivalents against 4.98B in total debt, resulting in a net debt position of -15.84B. Total book value stands at 34.86B, with working capital of 18.77B providing operational flexibility.

Hankook Cosmetics Co., Ltd produced 6.55B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -612.88M in capital expenditures, free cash flow totaled 5.94B - equivalent to 369.33 per share.

Over the twelve months ended June 30, 2026, Hankook Cosmetics Co., Ltd posted a gross margin of 50.61, reflecting its pricing power and cost economics. The operating margin of 0.74 and net profit margin of 1.08 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 5.83, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.94, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Hankook Cosmetics Co., Ltd shareholders.

As of June 30, 2026, Hankook Cosmetics Co., Ltd has an Altman Z-Score of 4.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.